Every record from Kestrel · page 6
Fast and inexpensive, on a 15-minute gradient that co-elutes mass-identical diastereomers. Results read high. Measured offset against the reference laboratory is +0.382 pp on 296 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019240 | BPC-157 | TFC | TFC-2507-J6580 | 2025-Q3 | 99.83 | 4.31 | 105.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019946 | 5-Amino-1MQ | SWB | SWB-2507-E6159 | 2025-Q3 | 99.93 | 6.60 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020261 | CJC-1295 (no DAC) | MKM | MKM-2504-K2481 | 2025-Q3 | 98.78 | 4.40 | 96.9 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020752 | Thymosin α1 | SGN | SGN-2504-P9721 | 2025-Q3 | 99.33 | 5.80 | 89.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019759 | GHK-Cu | HJ | HJ-2503-M3890 | 2025-Q3 | 99.93 | 2.57 | — | Supplier-supplied | 0 | PASS |
| AX-2025-021086 | PT-141 (Bremelanotide) | WXT | WXT-2507-R5522 | 2025-Q3 | 99.65 | 4.68 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019566 | Semaglutide | Homopeptide | HOMO-2506-M1846 | 2025-Q3 | 99.80 | 5.70 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019317 | Retatrutide | TFC | TFC-2508-H7325 | 2025-Q3 | 97.94 | 3.19 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020022 | MOTS-c | ERP | ERP-2508-M7270 | 2025-Q3 | 98.57 | 1.46 | 101.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020423 | Melanotan II | KP | KP-2508-J4716 | 2025-Q3 | 98.29 | 6.79 | 93.8 | Laboratory-retained | 1 | FAIL |
| AX-2025-019728 | PEG-MGF | HJ | HJ-2507-S2872 | 2025-Q3 | 98.39 | 7.82 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019948 | 5-Amino-1MQ | SWB | SWB-2507-E6159 | 2025-Q3 | 99.22 | 6.42 | 100.1 | Supplier-supplied | 2 | FAIL |
| AX-2025-019036 | BPC-157 | JEEP | JEEP-2506-R3035 | 2025-Q3 | 99.14 | 2.72 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018697 | Retatrutide | QSC | QSC-2502-D6580 | 2025-Q3 | 99.01 | 6.74 | 106.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021157 | TB-500 | WXT | WXT-2502-A5571 | 2025-Q3 | 98.06 | 2.92 | 103.5 | Buyer-sourced | 1 | FAIL |
| AX-2025-020035 | Retatrutide | ERP | ERP-2506-C7220 | 2025-Q3 | 98.54 | 4.95 | — | Buyer-sourced | 3 | FAIL |
| AX-2025-019315 | Retatrutide | TFC | TFC-2508-H7325 | 2025-Q3 | 98.03 | 3.05 | 88.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019139 | PEG-MGF | TFC | TFC-2507-M4201 | 2025-Q3 | 97.77 | 4.02 | 94.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018883 | Retatrutide | QSC | QSC-2504-R9199 | 2025-Q3 | 99.67 | 2.36 | 93.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020432 | GHRP-6 | KP | KP-2503-L4599 | 2025-Q3 | 98.43 | 4.37 | 101.5 | Supplier-supplied | 2 | FAIL |
| AX-2025-021056 | Sermorelin | WXT | WXT-2506-D4780 | 2025-Q3 | 98.94 | 5.77 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020415 | Melanotan II | KP | KP-2508-J4716 | 2025-Q3 | 98.24 | 6.52 | 96.3 | Supplier-supplied | 1 | FAIL |
| AX-2025-018861 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.31 | 4.25 | 93.6 | Supplier-supplied | 2 | FAIL |
| AX-2025-020988 | Enclomiphene citrate | CPC | CPC-2505-Y3713 | 2025-Q3 | 98.68 | 6.72 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019202 | TB-500 | TFC | TFC-2503-R5803 | 2025-Q3 | 99.16 | 3.22 | 95.4 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018616 | Pemvidutide | QYB | QYB-2502-V5083 | 2025-Q3 | 99.08 | 4.27 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019032 | BPC-157 | JEEP | JEEP-2504-X2669 | 2025-Q3 | 98.17 | 6.98 | 91.3 | Supplier-supplied | 2 | FAIL |
| AX-2025-020994 | Enclomiphene citrate | CPC | CPC-2505-Y3713 | 2025-Q3 | 98.63 | 6.31 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019319 | Retatrutide | TFC | TFC-2508-H7325 | 2025-Q3 | 97.98 | 3.97 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018677 | Dihexa | QYB | QYB-2503-Y6694 | 2025-Q3 | 99.93 | 8.20 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019466 | Retatrutide | Homopeptide | HOMO-2508-U9007 | 2025-Q3 | 98.58 | 6.79 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021047 | Semaglutide | WXT | WXT-2508-G4316 | 2025-Q3 | 99.03 | 3.12 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020191 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2507-S1153 | 2025-Q3 | 99.93 | 4.42 | 96.5 | Supplier-supplied | 1 | FAIL |
| AX-2025-018826 | SS-31 (Elamipretide) | QSC | QSC-2502-M8050 | 2025-Q3 | 99.93 | 4.98 | — | Supplier-supplied | 0 | PASS |
| AX-2025-021064 | Liraglutide | WXT | WXT-2504-L4924 | 2025-Q3 | 97.18 | 6.60 | 96.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-019464 | Retatrutide | Homopeptide | HOMO-2508-U9007 | 2025-Q3 | 99.93 | 6.34 | 100.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020118 | Tirzepatide | GGPeps | GGPE-2502-J8885 | 2025-Q3 | 99.28 | 5.65 | 95.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019739 | Ipamorelin | HJ | HJ-2504-X2985 | 2025-Q3 | 99.70 | 6.43 | 93.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019313 | MOTS-c | TFC | TFC-2503-C7376 | 2025-Q3 | 99.48 | 5.53 | 94.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020263 | BPC-157 | MKM | MKM-2502-T2878 | 2025-Q3 | 98.81 | 6.46 | 101.9 | Supplier-supplied | 0 | PASS |